Allarity Therapeutics Inc. (NASDAQ: ALLR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ALLARITY THERAPEUTICS INC.

Allarity Therapeutics Inc. (NASDAQ: ALLR)
Listen to this Section


$1.23
+0.0610 ( +5.21% ) 43.4K

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Market Data


Open $1.23
Previous Close $1.17
Volume 43.4K
Market Cap $18.62M
Day Range $1.15 - $1.23
52 Week Range $0.77 - $2.35
Shares Outstanding 15.91M
Change % +5.21%
Net Change ▲ 0.0610
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Aug 27, 2025
10-q Quarterly Reports 55 Aug 15, 2025
nt Quarterly Reports 1 Aug 14, 2025
8-k 8K-related 14 Jul 16, 2025
3 Insider transactions 1 Jul 14, 2025
8-k 8K-related 13 Jul 07, 2025
8-k 8K-related 14 Jul 01, 2025

Latest News